Articles published by Lineage Cell Therapeutics, Inc.
RG6501 (OpRegen®) Phase 1/2a Additional Results to Be Featured at 23rd EURETINA Congress
September 13, 2023
Via Business Wire
Tickers
LCTX
Via Business Wire
Tickers
LCTX
Via Business Wire
Tickers
LCTX
Via Business Wire
Tickers
LCTX
Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
Via Business Wire
Tickers
LCTX
Via Business Wire
Tickers
LCTX
Lineage to Present at Alliance for Regenerative Medicine 2022 Cell & Gene Meeting on the Mesa
October 04, 2022
Via Business Wire
Tickers
LCTX
Lineage Provides Update on Auditory Neuronal Cell Transplant Program for the Treatment of Hearing Loss
February 08, 2023
Via Business Wire
Tickers
LCTX
Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference
August 15, 2022
Via Business Wire
Tickers
LCTX
Via Business Wire
Tickers
LCTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.